← Leaderboards
William E Haskins
Gryphon Bio, Inc.
$2,220,250
Attributed
$2,220,250
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,220,250 · 2
By mechanism
R44$2,220,250 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- James Dale Berry · Brigham And Women'S Hospital$25,538,716
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
- Gary Fanger · Rise Therapeutics, Llc$17,847,765
Research focus
MediatingNeuroinflammationControlled Cortical ImpactLeadMouse ModelNeurobehavioralClinical DataComplexImmunotherapyIn VivoMorbidity - Disease RateMotorNerve DegenerationNervous System TraumaBindingAcuteBiological MarkersCognitiveFda ApprovedIgg1InjuryIn VitroMonoclonal AntibodiesNovel Therapeutics
Grant awards (3)
Development of Novel sgp130-Fc Bioconjugates for TBI$1,236,188
R44 · FY2025 · NS · contact PI
Development of Novel sgp130-Fc Bioconjugates for TBI$484,997
R44 · FY2023 · NS · contact PI
Temporal Biomarker-Powered Immunotherapy Targeting GFAP for Traumatic Brain Injury$499,065
R44 · FY2021 · NS · contact PI